Netscientific Regulatory News (NSCI)

NetScientific plc 

("NetScientific" or the "Company")

PDS Biotechnology proposed offering

NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio company PDS Biotechnology Corporation ("PDS") (Nasdaq:PDSB) today made a further announcement concerning its proposed offering to raise approximately US$12 million (c.£9.3 million).

PDS mentioned in today's announcement that, in connection with NetScientific's expression of interest to subscribe in its offering, upon consummation of the offering it will appoint a designee of NetScientific to its board of directors.

NertScientific is considering investing £0.5 million in the offering.

A further announcement will be made as soon as appropriate.

For more information, please contact:

NetScientific Tel: 020 3514 1800

Ian Postlethwaite, CEO and

CFO

Tel: 020 7220 1666

WH Ireland (NOMAD and Broker)

Chris Fielding / Darshan Patel